FORGOTTEN HISTORY: 112 - The Untold Story

Pfizer To Sell 23 Patented Drugs, Vaccines At Lower Prices To Poorer Countries

Pfizer Inc (NYSE:PFE) will sell over 20 patent-protected drugs and vaccines at not-for-profit prices to 45 of the world's poorest countries. Under the program, Pfizer will begin shipping the medicines first to Ghana, Malawi, Rwanda, Senegal, and Uganda before the end of this year, Chief Executive Albert Bourla said in an interview. This will…

Benzinga · May 25, 2022

Davos 2022: Will war in Ukraine derail international investment?

The war in Ukraine, supply chain problems, inflation, and labour shortages have been dominating the agenda at the World Economic Forum in Davos, where business and political leaders pitch investment and global collaborations. FRANCE 24 Business Editor Kate Moody has been speaking to Martin Shanahan, CEO of IDA Ireland, about…

France 24 · May 25, 2022

The price we pay for global supply chain

One is product shortages, as with the shortage of personal protective equipment early in the pandemic and recently with infant formula. But are we willing to pay higher prices for less reliance on the global supply chain?

Chicago Sun-Times · May 25, 2022

Who Can Beat Tesla On EV Sales? This Company CEO Believes So

Volkswagen AG (OTC:VWAGY) CEO Herbert Diess said Volkswagen can overtake Tesla, Inc. (NASDAQ:TSLA) as the world’s largest seller of electric vehicles by 2025, CNBC reported. Stabilizing supply chain woes would help the German carmaker to increase production in the coming months, the CEO said. He expects some relief from the semiconductor supply market to…

Benzinga · May 24, 2022

Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study

Caladrius Biosciences Inc (NASDAQ:CLBS) suspended patient enrollment in its Phase 2b FREEDOM Trial of Xowna for coronary microvascular dysfunction (CMD).  As previously communicated, the pandemic impacted the enrollment in the FREEDOM Trial coupled with supply chain issues making enrollment much slower and challenging to accelerate.  The FREEDOM trial enrolled approximately one-third of the…

Benzinga · May 24, 2022

Davos 2022: EU eyes ban on Russian oil as leaders discuss energy independence

With world leaders at Davos set to discuss energy independence and sustainability, Germany's economy minister says an EU ban on Russian oil could be "days away". Meanwhile, supply chain disruptions to the world economy are also on the agenda. FRANCE 24's Business Editor Kate Moody reports from the Swiss Alps.

France 24 · May 24, 2022

31 energy companies beg PM not to hit them with a windfall tax

There are calls for a one-off tax on companies making billions of pounds a month to help families unable to afford gas and electricity

Wales Online · May 24, 2022

Read How Analyst Reacted To Deere's Q2 Results

Deere & Company (NYSE:DE) reported second-quarter FY22 results on Friday; below are the reactions from the analysts. Wells Fargo analyst Seth Weber lowered the price target for Deere to $410 (an upside of 22%) from $455 while maintaining the Overweight rating on the shares. The analyst understands angst around the rebalance but doesn't…

Benzinga · May 23, 2022

5 Stocks to Buy on the Next Market Pullback

Persisting factors like the multi-decade high inflation, deepening supply chain constraints, and the expectation of a recession due to the Federal Reserve’s aggressive policy tightening could lead to a further market pullback. So, it could be wise to bet on fundamentally sound stocks Nutrien (NTR), Centene (CNC), Itochu (ITOCY), Steel…

StockNews.com · May 23, 2022

Telsey Advisory Cuts Price Target On This Sporting Goods Maker- Read Why

Telsey Advisory Group analyst Joseph Feldman lowered the price target on Dick's Sporting Goods Inc (NYSE:DKS) to $125 (65% upside) from $153 and kept an Outperform rating on the shares. The analyst expects DKS to have a challenging Q1 as it faces a shift in consumer spending away from discretionary categories, elevated freight costs, and…

Benzinga · May 23, 2022